Oramed Pharmaceuticals (ORMP) EBITDA Margin (QoQ) (2016 - 2023)
Oramed Pharmaceuticals (ORMP) EBITDA Margin (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 21,952.00 |
| Mar 31, 2023 | 58,151.00 |
| Dec 31, 2022 | -16,276.00 |
| Sep 30, 2022 | 49,318.00 |
| Jun 30, 2022 | -443.00 |
| Nov 30, 2019 | -1,604.00 |
| Aug 31, 2019 | 25,360.00 |
| May 31, 2019 | -6,221.00 |
| Feb 28, 2019 | 15,269.00 |
| Nov 30, 2018 | -17,789.00 |
| Aug 31, 2018 | 22,431.00 |
| May 31, 2018 | -21,978.00 |
| Feb 28, 2018 | -6,793.00 |
| Nov 30, 2017 | 1,451.00 |
| Aug 31, 2017 | -11,238.00 |
| May 31, 2017 | 20,147.00 |
| Feb 28, 2017 | -15,762.00 |
| Nov 30, 2016 | 427,572.00 |
| Aug 31, 2016 | -596,332.00 |
| May 31, 2016 | 282,408.00 |